Ranked #5,804 of 8,699 institutional investors
Blue Water Life Science Advisors, LP
Larkspur, CA
$225M
US stock portfolio at live prices · today −$5.9M (−2.56%)
Live prices, last trade 11:42 AM ET
- Value at quarter end (Q3 2026)
- $252M
- Change from Q2 2026
- +$92.8M (+58.47%)
- Positions
- 8 · 0 new, 1 sold out
- Filed
- Nov 13, 2026
Holdings
Q3 2026 13F, live pricesCDNA 54.7%ADPT 12.5%GH 9.75%TXG 9.23%NTRA 4.25%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| CDNA CareDx, Inc. | 1,740,000 | $123M | 54.7% | Added +46% |
| ADPT Adaptive Biotechnologies Corporation | 1,010,145 | $28.1M | 12.5% | Unchanged |
| GH Guardant Health, Inc. | 151,747 | $21.9M | 9.75% | Added +32% |
| TXG 10x Genomics, Inc. | 391,400 | $20.7M | 9.23% | Reduced −39% |
| NTRA Natera, Inc. | 34,494 | $9.6M | 4.25% | Unchanged |
| BLLN BillionToOne, Inc. | 104,000 | $9.3M | 4.13% | Added +49% |
| QTRX Quanterix Corporation | 3,474,202 | $6.3M | 2.82% | Unchanged |
| TEM Tempus AI, Inc. | 105,412 | $5.9M | 2.61% | Unchanged |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| PSNL Personalis, Inc. | 1,676,300 | $24.2M |